| Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome JF Bohlen, CM Cleary, D Das, SR Sripathy, N Sadowski, G Shim, ... Brain 146 (8), 3331-3346, 2023 | 5 | 2023 |
| TCF4 mutations disrupt synaptic function through dysregulation of RIMBP2 in patient-derived cortical neurons BA Davis, HY Chen, Z Ye, I Ostlund, M Tippani, D Das, SR Sripathy, ... Biological Psychiatry 95 (7), 662-675, 2024 | 3 | 2024 |
| Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders. G Shim, AI Romero-Morales, SR Sripathy, BJ Maher Frontiers in Cellular Neuroscience 17, 1322813, 2024 | 1 | 2024 |
| Psychiatric risk gene Transcription Factor 4 (TCF4) regulates the density and connectivity of distinct inhibitory interneuron subtypes HY Chen, BDN Phan, G Shim, GR Hamersky, N Sadowski, TS O’Donnell, ... Molecular Psychiatry, 1-14, 2023 | 1 | 2023 |
| Clemastine fumarate enhances myelination and promotes functional recovery in a syndromic ASD mouse model of Pitt-Hopkins Syndrome JF Bohlen, CM Cleary, D Das, SR Sripathy, NL Sadowski, G Shim, ... bioRxiv, 2022.05. 03.490512, 2022 | 1 | 2022 |
| 302. Investigating the Impact of Common Genetic Risk Variants for Schizophrenia on Neuronal Function Elucidates Relationships Between Cellular Phenotypes, Clinical Status and … SR Sripathy, SC Page, F Farinelli, Z Ye, Y Wang, D Das, G Shim, DJ Hiler, ... Biological Psychiatry 93 (9), S216, 2023 | | 2023 |
| 301. Pro-Myelinating Drugs Promote Functional Recovery in an ASD Mouse Model of Pitt-Hopkins Syndrome J Bohlen, C Cleary, D Das, SR Sripathy, N Sadowski, G Shim, R Kenney, ... Biological Psychiatry 93 (9), S215, 2023 | | 2023 |
